Smash Notes
Cambrian Biopharma's James Peyer: "70 will be the new 50" artwork

Danny in the Valley

Cambrian Biopharma's James Peyer: "70 will be the new 50"

The Sunday Times’ tech correspondent brings on James Peyer, co-founder of Cambrian Biopharma, to talk about the unique structure of his startup (6:30), the goal (8:45), alighting on longevity as a 15-year-old (12:45), why the field has matured (15:40), what he chooses to focus on (19:50), getting drugs to market (24:55), raising money (32:00), why he chose…

Notes

No notes here yet.

Weekly highlights

One letter a week.

The notes worth hearing, with the minute they were said.